Efficacy of sirolimus-eluting stent implantation in diabetic patients with very small vessels (≤2.25 mm). Insights from the DIABETES trial;Eficacia de la implantación del stent recubierto de rapamicina en pacientes diabéticos con vasos muy pequeños (≤2,25 mm). Subanálisis del estudio DIABETES

Revista Espanola de Cardiologia

Volumn 59, Issue 10, 2006, Pages 1000-1007

  Jiménez Quevedo, Pilar ^a   Sabaté, Manel ^a,f   Angiolillo, Dominick J ^a   Alfonso, Fernando ^a   Hernández Antolin, Rosana ^a   Gómez Hospital, José A ^b   Sanmartín, Marcelo ^c   Bañuelos, Camino ^a   Moreno, Raúl ^a   Escaned, Javier ^a   Fernández, Cristina ^a   Costa, Marco A ^d   Fernández Avilés, Francisco ^e   Macaya, Carlos ^a  

^a HOSPITAL CLÍNICO SAN CARLOS   (Spain)

^b HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^c HOSPITAL DO MEIXOEIRO   (Spain)

^d UNIVERSITY OF FLORIDA   (United States)

^e HOSPITAL CLÍNICO UNIVERSITARIO DE VALLADOLID   (Spain)

^f HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

Author keywords

Coronary angioplasty; Diabetes mellitus; Drug eluting stent; Small vessels

Indexed keywords

ANTITHROMBOCYTIC AGENT; FIBRINOGEN RECEPTOR ANTAGONIST; INSULIN; RAPAMYCIN;

ADULT; AGED; ANGIOGRAPHY; ARTICLE; BLOOD VESSEL; CONTROLLED STUDY; DIABETES MELLITUS; DRUG ELUTING STENT; FEMALE; FOLLOW UP; HIGH RISK PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; PERCUTANEOUS CORONARY INTERVENTION; RESTENOSIS; SAFETY; THROMBOSIS; TRANSLUMINAL CORONARY ANGIOPLASTY;

EID: 34547939404     PISSN: 03008932     EISSN: None     Source Type: Journal    
DOI: 10.1157/13093976     Document Type: Article

References (22)

1. Laakso M, Lehto S. Epidemiology of macrovascular disease in diabetes. Diabetes Rev. 1997;5:294-315.
2. Zueco Gil J. Importancia de los factores clínicos y anatómicos en el intervencionismo coronario. Rev Esp Cardiol. 2005;58:430-41.
3. Kastrati A, Schomig A, Elezi S, Schuhlen H, Dirschinger J, Hadamitzky M, et al. Predictive factors of restenosis after coronary stent placement. J Am Coll Cardiol. 1997;30:1428-36.
4. Bauters C, Hubert E, Prat A, Bougrimi K, Van Belle E, McFadden EP, et al. Predictors of restenosis after coronary stent implantation. J Am Coll Cardiol. 1998;31:1291-8.
5. Suselbeck T, Latsch A, Siri H, Gonska B, Poerner T, Pfleger S, et al. Role of vessel size as a predictor for the occurrence of in-stent restenosis in patients with diabetes mellitus. Am J Cardiol. 2001; 88:243-7.
6. Morice MC, Serruys PW, Sousa JE, Fajadet J, Ban Hayashi E, Perin M, et al. A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. N Engl J Med. 2002;346:1773-80.
7. Moses JW, Leon MB, Popma JJ, Fitzgerald PJ, Holmes DR, O'S-haughnessy C, et al. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med. 2003;349:1315-23.
8. Sabaté M, Jiménez-Quevedo P, Angiolillo DJ, Gomez-Hospital JA, Alfonso F, Hernandez-Antolín R, et al. Randomized comparison of sirolimus-eluting stent versus standard stent for percutaneous coronary revascularization in diabetic patients: the diabetes and sirolimus-eluting stent (DIABETES) trial. Circulation. 2005; 112:2175-83.
9. Berenguer A, Mainar V, Bordes P, Valencia J, Gómez S. Utilidad de los stents recubiertos de rapamicina en pacientes diabéticos con lesiones coronarias complejas. Rev Esp Cardiol. 2006;59: 117-24.
10. Sabaté M. Insulino dependencia, ¿rapamicina resistencia? Rev Esp Cardiol. 2006;59:91-3.
11. Kip KE, Faxon DP, Detre KM, Yeh W, Kelsey SF, Currier JW. Coronary angioplasty in diabetic patients. The National Heart, Lung, and Blood Institute Percutaneous Transluminal Coronary Angioplasty Registry. Circulation. 1996;94:1818-25.
12. Shah PJ, Gordon I, Fuller J, Seevanayagam S, Rosalion A, Tatoulis J, et al. Factors affecting saphenous vein graft patency: clinical and angiographic study in 1402 symptomatic patients operated on between 1977 and 1999. J Thorac Cardiovasc Surg. 2003;126: 1972-7.
13. Schofer J, Schluter M, Gershlick AH, Wijns W, Garcia E, Schampaert E, et al. Sirolimus-eluting stents for treatment of patients with long atherosclerotic lesions in small coronary arteries: double-blind, randomised controlled trial (E-SIRIUS). Lancet. 2003;362:1093-9.
14. Degertekin M, Serruys PW, Tanabe K, Lee CH, Sousa JE, Colombo A, et al. Long-term follow-up of incomplete stent apposition in patients who received sirolimus-eluting stent for de novo coronary lesions: an intravascular ultrasound analysis. Circulation. 2003;108:2747-50.
15. Jimenez-Quevedo P, Sabate M, Angiolillo DJ, Costa MA, Alfonso F, Gomez-Hospital JA, et al. Vascular effects of sirolimus-eluting versus bare metal stents in diabetic patients: three-dimensional ultrasound results of the DIABETES Trial. J Am Coll Cardiol. 2006;47:2172-9.
16. Ardissino D, Cavallini C, Bramucci E, Indolfi C, Marzocchi A, Manari A, et al. Sirolimus-eluting vs uncoated stents for prevention of restenosis in small coronary arteries: a randomized trial. JAMA. 2004;292:2727-34.
17. Ortolan P, Ardissino D, Cavallini C, Bramucci E, Indolfi C, Aquilina M, et al. Effect of sirolimus-eluting stent in diabetic patients with small coronary arteries (a SES-SMART substudy). Am J Cardiol. 2005;96:1393-8.
18. Moussa I, Leon MB, Baim DS, O'Neill WW, Popma JJ, Buch-binder M, et al. Impact of sirolimus-eluting stents on outcome in diabetic patients: a SIRIUS (SIRolImUS-coated Bx Velocity balloon-expandable stent in the treatment of patients with de novo coronary artery lesions) substudy. Circulation. 2004;109:2273-8.
19. Angiolillo DJ, Sabate M, Alfonso F, Macaya C. Candy wrapper effect after drug-eluting stent implantation: deja vu or stumbling over the same stone again? Catheter Cardiovasc Interv. 2004;61: 387-91.
20. Moreno R, Fernández C, Hernández R, Alfonso F, Angiolillo DJ, Sabate M, et al. Drug-eluting stent thrombosis: results from a pooled analysis including 10 randomized studies. J Am Coll Cardiol. 2005;45:954-9.
21. Holmes DR Jr, Leon MB, Moses JW, Popma JJ, Cutlip D, Fitzgerald PJ, et al. Analysis of 1-year clinical outcomes in the SIRIUS trial: a randomized trial of a sirolimus-eluting stent versus a standard stent in patients at high risk for coronary restenosis. Circulation. 2004;109:634-40.
22. Schampaert E, Cohen EA, Schluter M, Reeves F, Traboulsi M, Title LM, et al. The Canadian study of the sirolimus-eluting stent in the treatment of patients with long de novo lesions in small native coronary arteries (C-SIRIUS). J Am Coll Cardiol. 2004;43: 1110-5.